One of the world’s leading medical technology providers in the fields of ophthalmology and neuro/ENT surgery selects clinivation WorldView® as their enterprise solution for on-demand global regulatory intelligence.
Natick, MA, October 1, 2008 – clinivation, Inc. announced today that Carl Zeiss Meditec has selected the clinivation WorldView® enterprise solution for On-Demand Global Regulatory Intelligence. “Carl Zeiss Meditec is an innovative global leader in the fields of ophthalmology and neuro/ENT, and we are pleased that they have chosen clinivation WorldView® for comprehensive, authoritative, and up-to-date global regulatory intelligence,” said Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions.
About clinivation WorldView® On-Demand Global Regulatory Intelligence
Clinivation WorldView® is the medical device and diagnostic industry’s most comprehensive, authoritative, and up-to-date enterprise solution for On-Demand Global Regulatory Intelligence. Providing clear, step-by-step market clearance regulations, processes, and guidance for >99% of the world markets, only clinivation WorldView® delivers tried-and-true intelligence from certified, practicing professionals with real-world experience.
About Carl Zeiss Meditec
Headquartered in Germany, Carl Zeiss Meditec develops, manufactures, sells, and services diagnostic and therapeutic devices for ophthalmology, visualization solutions for ophthalmology, neuro/ENT, dental, and spine, and advanced radiation therapy systems. The company’s medical technologies are designed to help improve the quality of life of millions of people worldwide by enhancing or preserving vision, mobility, and cognitive ability.
In the field of ophthalmology, Carl Zeiss Meditec offers complete solutions for treating the four main eye ailments: vision defects (refraction), cataract, glaucoma and retinal disorders. Its products support doctors and patients to diagnose and treat these ailments efficiently and precisely, thus giving both groups clear benefits, not least by offering them a comprehensive disease management solution.
Furthermore, Carl Zeiss Meditec has secured an outstanding starting position in the growth market of neuro/ENT surgery. As the world’s leading provider of surgical microscopes and visualization solutions for these treatments, the company intends to further expand its footprint in this area through organic growth and strategic expansion into adjacent market segments.
With subsidiaries in France, Spain, North America, and Japan, Carl Zeiss Meditec has almost 2,000 employees worldwide, and a strong presence in the world’s key markets. The company uses the efficient distribution network of the Carl Zeiss Group (comprising about 40 distribution companies and over 100 agencies worldwide) to gain the edge needed to prevail in global competition.
For more information, please visit www.meditec.zeiss.com.
About the Carl Zeiss Group
The Carl Zeiss Group (headquartered in Germany) is a globally leading group of companies in the optical and opto-electronic industry. As an innovative provider of products and services in a future-oriented key industry, Carl Zeiss numbers among the world’s most research-intensive high-tech companies. Carl Zeiss has offices in over 30 countries and are represented in more than 100 countries, with production centers in Europe, North America, Central America, and Asia.